Skip to main content
Retour
Watch Compare

Medicale Corp.

Qualité des données : 83%
MCLE
OTC Services Health Services
0,10 €
▼ 0,05 € (-33,33%)
Cap. Boursière: 592 000,0
Prix
0,10 €
Cap. Boursière
592 000,0
Fourchette du Jour
—
Fourchette 52 Semaines
—
Volume
—
Ouverture —
Moyenne 50J / 200J
—
Moyenne 50J / 200J
—

Quick Summary

Points Clés

Negative free cash flow of -19 748,0

Croissance

Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Qualité

Return on Equity
N/A
ROICN/A
Net MarginN/A
Op. MarginN/A

Sécurité

Debt / Equity
N/A
Current Ratio0,00
Interest Coverage-2,66

Valorisation

PE (TTM)
-17,53
En dessous de la moyenne du secteur (-1,17)
P/B RatioN/A
EV/EBITDAN/A
Dividend YieldN/A

Historique des Prix

Tendances Financières

Comparaison Sectorielle

vs médiane du secteur Services (502 pairs)
Métrique Action Médiane du Secteur
P/E -17,5 -1,2
P/B — 1,4
ROE % — -16,0
Net Margin % — -18,3
Rev Growth 5Y % — 4,2
D/E — 0,4

Objectif de Cours des Analystes

Aucune couverture d'analyste disponible

Estimations de Bénéfices

Aucune estimation prévisionnelle disponible

All Fundamental Metrics
Growth
Revenue Growth (1Y) N/A Revenue Growth (3Y) N/A
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) N/A Net Income (TTM) -33 763,0
ROE N/A ROA N/A
Gross Margin N/A Operating Margin N/A
Net Margin N/A Free Cash Flow (TTM) -19 748,0
ROIC N/A FCF Growth (3Y) N/A
Safety
Debt / Equity N/A Current Ratio 0,00
Interest Coverage -2,66 Asset Turnover N/A
Working Capital -32 202 Tangible Book Value -145 376
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -17,53 Forward P/E N/A
P/B Ratio N/A P/S Ratio N/A
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -3,34%
Market Cap 592 000,0 Enterprise Value 592 000,0
Per Share
EPS (Diluted TTM) -0,01 Revenue / Share N/A
FCF / Share 0,00 OCF / Share 0,00
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue N/A FCF Conversion 58,49%
SBC-Adj. FCF N/A Growth Momentum N/A

Income Statement

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue — — — 0,0 0,0
Net Income -41 153,0 -58 213,0 -37 138,0 -46 419,0 -32 152,0
EPS (Diluted) -0,01 -0,01 -0,01 -0,01 —
Gross Profit — — — — —
Operating Income -33 493,0 -54 707,0 -37 593,0 -46 419,0 -32 152,0
EBITDA — — — — —
R&D Expenses — — — — —
SG&A Expenses — — — — —
D&A — — — — —
Interest Expense 7 501,0 3 506,0 — — —
Income Tax 0,0 0,0 0,0 0,0 0,0

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 0,0 159,0 159,0 0,0 28 275,0
Total Liabilities 140 086,0 99 092,0 — — —
Shareholders' Equity -140 086,0 -98 933,0 -40 720,0 -54 774,0 -8 355,0
Total Debt — — — — —
Cash & Equivalents — — — — 18 475,0
Current Assets 0,0 159,0 159,0 0,0 18 675,0
Current Liabilities 33 652,0 15 507,0 40 879,0 54 774,0 36 630,0